M&A Transactions 

  • A large industrial company in its roll up various automotive glass companies.
  • A large Japanese multinational in its sale and assignment of rights to develop and market certain products in all countries excluding Mexico.
  • A privately held company in its sale of all of its assets for an upfront and contingent payments totaling more than $500 million. 
  • A multinational company in its sale of its U.S. Subsidiary
  • A multinational company in its acquisition of chemical companies in the United States
  • A company in its sale to private equity for over $500 million 
  • Sale of carbon recapture company to a multinational company
  • Indian-based company in its acquisition of an energy facility in the United States  

Partnering (includes Licensing, Collaboration, Co-Development, and Commercialization)

  • U.S. publicly traded company in a multinational license agreement with a Chinese company with a value of over $1 billion in milestone and royalty payments
  • Ivy League university in its Research and Development, Collaboration, License and Option Agreement with a multinational company with a value of $2 billion 
  • Japanese pharmaceutical company in a license agreement with a German multinational company
  • U.S. pharmaceutical company in its License and Asset Purchase Agreement with a Swiss multinational
  • U.S. company in its licensing transaction with a Canadian company to commercialize its products in Canada
  • Japanese company in its $320 million collaboration and development with U.S. multinational company
  • Multinational company in its up to $440 million Collaboration Agreement with a competitor for the development and commercialization of three products 
  • U.S. agriculture company in its development and commercialization of certain of its products in Europe by a French company providing 41 Million Euros in upfront and milestone payments  
  • U.S. publicly traded company in its royalty monetization deals with another U.S. publicly traded company

General Corporate

  • U.S. publicly traded company in relation to its various research, development and manufacturing agreements
  • Global pharmaceutical corporation in connection with numerous clinical study agreements
  • U.S. pharmaceutical corporation regarding high-volume clinical study agreements and drafting standard clinical trial documentation
  • U.S. publicly traded company in its development of its multinational manufacturing supply chain, including negotiation of its manufacturing and supply agreements with Italian, Japanese, and U.S.-based manufacturing companies
  • U.S. publicly traded company in relation to its various research, development and manufacturing agreements
  • Ivy League university and various national and global companies in drafting and development of their corporate and commercial form agreements
  • Various companies in their corporate development process from formation through public offering and capital markets transactions